Spots Global Cancer Trial Database for Hypofractionated Radiosurgery for Localised Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hypofractionated Radiosurgery for Localised Prostate Cancer
Official Title: Hypofractionated Radiosurgery for Localised Prostate Cancer
Study ID: NCT02635256
Conditions
Interventions
Study Description
Brief Summary: Hypofractionated radiosurgery has been investigated in a few trials and appears to be safe and feasible. Investigators initiated this multicenter phase II prospective trial to analyse feasibility (toxicity) of hypofractionated radiosurgery with 5 fractions in patients with localised prostate cancer, who are ineligible for the "PREFERE trial" under the hypothesis that the ratio of patients with late toxicity ≥ grade 2 after 1 year amounts 2,8% and is significant lower than 17.5%.
Detailed Description: Experimental radiosurgery of prostate with 5 fractions each with 7,00 Gy (total application rate of 35,00 Gy). Planned visits are: Baseline, visits at every radiation day and four follow ups (4-6 weeks, 3 months, 6 months and one year after last day of radiation).
Eligibility
Minimum Age: 60 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Saphir Radiosurgery Center Frankfurt am Main, Frankfurt am Main, , Germany
University Hospital Frankfurt, Department of Radiation Therapy and Oncology, Frankfurt am Main, , Germany
Saphir Radiosurgery Center Northern Germany, Güstrow, , Germany
University Medical Center Schleswig-Holstein, Kiel, , Germany
European Cyberknife Center Munich, Munich, , Germany
Contact Details
Name: Juergen Dunst, Prof.
Affiliation: University Hospital Schleswig-Holstein
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
